In the News
Advancing Alzheimer’s Research
2020 Citizen Scientist Cornerstone Award National Honoree Dr. Collins Lewis was featured for his efforts to encourage people from different racial backgrounds to participate in Alzheimer’s clinical trials. It’s not hard to understand why most medical research projects would benefit from a robust, varied set of study subjects. But sometimes, the pool of participants doesn’t […]
National Alzheimer’s Disease Awareness Month: Lou Ruvo Center
GAP-Net site Lou Ruvo Center in Las Vegas was featured for National Alzheimer’s Disease Awareness Month. The full interview can be found using the link at the bottom of this page. In Las Vegas, there are nearly 50,000 people battling the disease and more than 5 million around the country. The challenges of a loved […]
TRC-PAD Funnel Finally Touches Down
GAP was mentioned for our partnering with the European Prevention of Alzheimer’s Dementia (EPAD) to bring diversity and more volunteers to clinical trials. Recruiting asymptomatic participants for secondary prevention trials such as AHEAD 3-45 is no small feat. How do you find people who are well on the road to Alzheimer’s disease but feel fine, […]
Senior’s Honors and Recognition in St. Louis Times
2020 Citizen Scientist Awards National Cornerstone Honoree Dr. Collins Lewis was featured in the St. Louis Times for his participation in Alzheimer’s clinical trials. NATIONAL CITIZEN SCIENTIST CORNERSTONE AWARD The Global Alzheimer’s Platform Foundation® (GAP) has recognized St. Louis psychiatrist Dr. Collins Lewis as the honoree of the National Citizen Scientist Cornerstone Award®. The Charles […]
Breakthrough Alzheimer’s Study Finds First Patient in CNY
GAP-Net site Clarity Clinical Research enrolls the first participant in the Green Memory Study out of 200 participating clinics. As the two walk through the heart of Jordan, his head is filled with facts and memories. “There’s some nice little antiques in there,” Mark says, passing a store. “The kids would go swimming down there,” […]
Global Alzheimer’s Platform Foundation® President Testifies before FDA Advisory Committee in Support of Breakthrough Alzheimer’s Drug
GAP President John Dwyer says aducanumab offers disease-modifying benefit significantly exceeding current therapies Contact: Pamela Larkin, 408-466-5952, [email protected] Washington, DC (November 6, 2020) – Today, the President of the Global Alzheimer’s Platform Foundation® (GAP), John Dwyer, testified before the FDA’s Peripheral and Central Nervous System Drugs Advisory Committee regarding Biogen’s breakthrough Alzheimer’s drug aducanumab. Given that clinical […]
State Rep. Willhite Receives National Award for Alzheimer’s Disease Volunteerism
2020 Citizen Scientist National Collaborator Awardee, Rep. Matt Willhite from GAP-Net site JEM Research Institute, was featured for his involvement and support for his mother’s Alzheimer’s clinical trial. The Global Alzheimer’s Platform Foundation (GAP) has recognized State Rep. Matt Willhite (D-District 86) as the honoree of the National Citizen Scientist Collaborator Award. JEM Research Institute, […]
5 Alzheimer’s Clinical Trial Volunteers Nominated for National Awards
GAP-Net site ADMDC at Lifespan Rhode Island Hospital’s citizen scientist nominees were featured about their involvement, as well as GAP President John Dwyer. The Alzheimer’s Disease and Memory Disorders Center (ADMDC) at Lifespan Rhode Island Hospital, a national leader in Alzheimer’s disease care and research, has nominated five clinical trial volunteers for the Global Alzheimer’s Platform Foundation’s (GAP) 2020 National Citizen Scientists Awards®. These […]
Westford Man Works for Alzheimer’s Cause
2020 Citizen Scientist Catalyst Award Honoree, Dennis Chan, was interviewed on his involvement with Alzheimer’s clinical trials and why it’s important to him. When Dennis Chan’s wife started to struggle with memory loss, the family began a quest to learn more. They began seeking more information about Alzheimer’s disease — a progressive disease that leads […]
STATEMENT: BLOOD TEST FOR ALZHEIMER’S IS A MAJOR ADVANCEMENT FOR PATIENTS, RESEARCHERS & PHYSICIANS
Contact: Pamela Larkin, 408-466-5952, [email protected] Washington, DC (October 29, 2020) – The President of the Global Alzheimer’s Platform Foundation (GAP), John Dwyer, issued the following statement regarding C2N Diagnostics’ release of the PrecivityADTM blood test. “Congratulations to the C2N Diagnostics team for successfully developing the first blood test of its kind for Alzheimer’s disease. It will transform […]